IL6 and systemic sclerosis: These medications are biologic agents that target the IL6 signaling pathway and have been clinically used for treating various autoimmune diseases associated with IL6, including rheumatoid arthritis, systemic sclerosis, giant cell arteritis, and juvenile idiopathic arthritis.